The Impact of Physician-Pharmaceutical Industry Interactions on Physician Prescriptions (의사-제약회사 상호작용이 처방에 미치는 영향)

HONG, JINPYO (홍진표); 박상은; KOH YS (고윤석)

doi:10.35301/ksme.2011.14.2.203

The Impact of Physician-Pharmaceutical Industry Interactions on Physician Prescriptions

Korean Journal of Medical Ethics
Abbr : 의료윤리
2011, 14(2), pp.203-213
DOI : 10.35301/ksme.2011.14.2.203
Publisher : The Korean Society For Medical Ethics
Research Area : Medicine and Pharmacy > General Medicine
Published : June 30, 2011

HONG, JINPYO ¹, 박상은 ², KOH YS ¹

¹울산대학교
²샘안양병원

Accredited

ABSTRACT

The relationship between the medical profession and the pharmaceutical industry has received considerable attention in recent years in Korea. In this article we examine the impact of physicianpharmaceutical industry interaction (PPII) on physician prescriptions. While physicians’ decisions concerning prescriptions are influenced by many factors, two of the most influential are the visits of sales representatives from pharmaceutical companies and the gifts and other enticements that pharmaceutical companies provide for physicians. Patients regard gifts from pharmaceutical companies as less appropriate and more influential than do physicians. Inappropriate relations between physicians and pharmaceutical companies can damage physician-patient relationships and harm the medical profession as a whole. Recent investigations in the United States and Korea have found many illegalities in physician-pharmaceutical industry interaction. The article argues for the urgent need to develop clear ethical codes and compliance mechanisms concerning PPII.

KEYWORDS

physician-pharmaceutical industry interaction, marketing, prescriptions

Citation status

* References for papers published after 2023 are currently being built.

[journal] Avorn J / 1982 / Scientific versus commercial sources of influence on the prescribing behaviour of physicians / Am J Med 73 : 4~8

[journal] Bloor K / 1996 / Lessons from international experience in controlling pharmaceutical expenditure II: Influencing doctors / BMJ 312 : 1525~1527

[journal] Campbell EG / 2007 / A national survey of physician-industry relationships / N Engl J Med 356(17) : 1742~1750

[journal] Chren MM / 1989 / Doctors, drug companies, and / JAMA 262(24) : 3448~3451

[journal] Chren MM / 1994 / Physician’s behavior and their interaction with drug company / JAMA 271 : 684~689

[book] Coleman JS / 1966 / Medical Innovation- A Diffusion study / Bobbs-Merril

[journal] Feely J / 1999 / The influence of hospital based prescribers on prescribing in general practice / Pharmacoeconomics 16 : 175~181

[journal] Gibbons RV / 1998 / A comparison of physicians’and patients’attitudes toward pharmaceutical industry gifts / J Gen Intern Med 13(3) : 151~154

[journal] Granja M / 2005 / Dangerous liaisons-physicians and pharmaceutical sales representatives / Acta Med Port 18(1) : 61~68

[journal] Hassel K / 2003 / Cost to patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparison / Eur J Public Health 13(1) : 18~23

[journal] Hodges B / 1995 / Interactions with the pharmaceutical industry: Experiences and attitudes of psychiatry residents, interns and clerks / CMAJ 153 : 553~559

[journal] Katz D / 2003 / All gifts large and small: Toward an understanding of the ethics of pharmaceutical industry giftgiving / Am J Bioethics 3(3) : 39~46

[journal] McKoy JM / 2005 / Caveat Medicus: Consequences of Federal Investigations of Marketing Activities of Pharmaceutical Suppliers of Prostate Cancer Drugs / J Clin Oncol 23(34) : 8894~8905

[journal] Orlowski JP / 1992 / The effects of pharmaceutical firm enticements on physician prescribing patterns. There’s no such thing as a free lunch / Chest 102 : 270~273

[journal] Peay M / 1988 / The role of commercial sources in the adoption of a new drug / Soc Sci Med 26 : 1183~1189

[web] / Problems of Irrational Drug Use-Session Guide / http://dcc2.bumc.bu.edu/prdu/Session_Guides/problems_of_irrational_drug_use.htm

[journal] Prosser H / 2003 / Influences on GPs’decision to prescribe new drugs ? the importance of who says what / Family Practice 20(1) : 61~68

[journal] Shaughnessy AF / 1994 / Separating the wheat from the chaff: Identifying fallacies in pharmaceutical promotion / J Gen Intern Med 9(10) : 563~568

[journal] Sondergaard J / 2009 / Impact of pharmaceutical representative visits on GPs’drug preferences / Family Pract 26(3) : 204~209

[journal] Wazana A / 2000 / Physicians and the pharmaceutical industry: is a gift ever just a gift? / JAMA 283 : 373~380

[journal] Winik C / 1961 / The diffusion of an innovation among physicians in a large city / Sociometry 24 : 384~

[journal] Woollard RF / 1993 / Addressing the pharmaceutical industry’s influence on professional behavior / CMAJ 149 : 403~404

[other] 건강보험심사평가원 / 2008 / 처방전당 약품목수 평가결과 공개

[journal] 고윤석 / 2004 / A survey for Professors' opinions of medical ethics subjects in Korean University Hospitals located in Seoul and Gyeonggi Province. / 한국의료윤리학회지 / 한국의료윤리학회 7(2) : 130~140

[other] 공정거래위원회 / 2009 / 7개 제약회사의 부당고객유인행위 등에 대한 조치결과. 2009. 1. 15. 보도자료

[thesis] 하재건 / 2010 / 우리나라의 제약산업 발전방향에 관한 연구 / 석사 / 단국대경영대학원

KJCKorea
Journal Central

Korean Journal of Medical Ethics 2023 KCI Impact Factor : 1.21

The Impact of Physician-Pharmaceutical Industry Interactions on Physician Prescriptions

ABSTRACT

KEYWORDS

Citation status

* References for papers published after 2023 are currently being built.

Korean Journal of Medical Ethics 2023 KCI Impact Factor : 1.21

The Impact of Physician-Pharmaceutical Industry Interactions on Physician Prescriptions

ABSTRACT

KEYWORDS

Statistics

Tools

Issue List

Citation status

KCI Citation Counts (5)

REFERENCES (26) * References for papers published after 2023 are currently being built.

Search PDF

Citation

* References for papers published after 2023 are currently being built.